---
title: "ZeroStack Corp. 1Q 2026: Revenue $7.27M, EPS $(3.68) — 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285055532.md"
description: "ZeroStack Corp. reported Q1 2026 revenue of $7.27M, a 5.9% increase from $6.87M in Q1 2025. The company faced a net loss of $(36.66) M and a diluted EPS of $(3.68). Revenue growth was attributed to Phatebo pharmaceutical sales and $2.8M from staking rewards. ZeroStack is focusing on digital-asset staking as a core revenue stream and has taken steps to regain Nasdaq compliance by appointing independent directors and rebuilding committees."
datetime: "2026-05-04T10:11:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285055532.md)
  - [en](https://longbridge.com/en/news/285055532.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285055532.md)
---

# ZeroStack Corp. 1Q 2026: Revenue $7.27M, EPS $(3.68) — 10-Q Summary

ZeroStack Corp. reported first-quarter 2026 results with revenue of $7.27M, up 5.9% from $6.87M a year earlier, while the company recorded a net loss of $(36.66) M and diluted loss per share of $(3.68) for the quarter.

**Financial Highlights**

-   Revenue: $7.274M for Q1 2026, up from $6.866M in Q1 2025 (5.9% YoY).
-   Net income: Net loss of $(36.660) M for Q1 2026 versus net loss of $(0.758) M in Q1 2025.
-   Diluted EPS: $(3.68) for Q1 2026 versus $(1.54) in Q1 2025.

**Business Highlights**

-   Revenue growth was driven by Phatebo pharmaceutical sales and approximately $2.8M of staking rewards recognized after the company began staking 0G Tokens on Jan. 21, 2026.
-   ZeroStack has shifted part of its go-to-market mix to include digital-asset staking as a core revenue stream following completed PIPE and token financings and material 0G token contributions.
-   Phatebo continues global pharmaceutical distribution across 28 countries and supports EU logistics operations.
-   Corporate governance steps to regain Nasdaq compliance included appointing independent directors and rebuilding key committees.

Original SEC Filing: ZeroStack Corp. \[ ZSTK \] - 10-Q - May. 01, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ZSTK.US](https://longbridge.com/en/quote/ZSTK.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [ALKS: Q2 2026 revenue and profitability surged following the Avadel acquisition and product growth](https://longbridge.com/en/news/294060584.md)
- [Emeis posts 2026 first-half financial report for Jan. 1-June 30 period](https://longbridge.com/en/news/294401924.md)
- [Ascopiave announces filing of H1 2026 interim financial report](https://longbridge.com/en/news/294500822.md)
- [Grupo Clarin schedules webcast to discuss second-quarter 2026 results](https://longbridge.com/en/news/294738587.md)
- [Sonoma Pharmaceuticals announces annual shareholder meeting](https://longbridge.com/en/news/294112885.md)